DoubleLine ETF Adviser LP Sells 181 Shares of The Clorox Company (NYSE:CLX)

DoubleLine ETF Adviser LP cut its stake in The Clorox Company (NYSE:CLX) by 3.4% in the second quarter, Holdings Channel reports. The firm owned 5,149 shares of the company’s stock after selling 181 shares during the period. DoubleLine ETF Adviser LP’s holdings in Clorox were worth $703,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of the stock. CIBC Private Wealth Group LLC boosted its stake in Clorox by 0.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 13,900 shares of the company’s stock worth $1,982,000 after purchasing an additional 66 shares in the last quarter. Lindbrook Capital LLC boosted its stake in Clorox by 6.2% in the 1st quarter. Lindbrook Capital LLC now owns 1,182 shares of the company’s stock worth $181,000 after purchasing an additional 69 shares in the last quarter. Fiduciary Group LLC boosted its stake in Clorox by 0.4% in the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock worth $2,600,000 after purchasing an additional 72 shares in the last quarter. GHP Investment Advisors Inc. boosted its stake in Clorox by 2.0% in the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock worth $496,000 after purchasing an additional 72 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. boosted its stake in Clorox by 5.1% in the 2nd quarter. Mesirow Financial Investment Management Inc. now owns 1,702 shares of the company’s stock worth $233,000 after purchasing an additional 83 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.51% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

CLX has been the subject of a number of recent analyst reports. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a research note on Friday, September 6th. JPMorgan Chase & Co. reduced their price target on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating for the company in a research report on Friday, August 2nd. Wells Fargo & Company reduced their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a research report on Wednesday, July 10th. Citigroup raised their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Finally, Deutsche Bank Aktiengesellschaft raised their price target on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Six equities research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and an average target price of $143.33.

Clorox Price Performance

NYSE:CLX opened at $161.91 on Friday. The company has a debt-to-equity ratio of 5.04, a current ratio of 1.03 and a quick ratio of 0.63. The firm has a market cap of $20.11 billion, a price-to-earnings ratio of 83.89, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40. The company has a 50 day moving average price of $150.84 and a 200-day moving average price of $143.96. The Clorox Company has a 1-year low of $114.68 and a 1-year high of $169.09.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.28. The firm had revenue of $1.90 billion during the quarter, compared to analyst estimates of $1.97 billion. Clorox had a net margin of 3.95% and a return on equity of 281.12%. Equities research analysts forecast that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a yield of 3.01%. Clorox’s dividend payout ratio is currently 252.85%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.